158 related articles for article (PubMed ID: 10908085)
1. Beta-blockade in adriamycin-induced cardiomyopathy.
Noori A; Lindenfeld J; Wolfel E; Ferguson D; Bristow MR; Lowes BD
J Card Fail; 2000 Jun; 6(2):115-9. PubMed ID: 10908085
[TBL] [Abstract][Full Text] [Related]
2. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
[TBL] [Abstract][Full Text] [Related]
3. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
4. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
[TBL] [Abstract][Full Text] [Related]
5. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
7. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
[TBL] [Abstract][Full Text] [Related]
8. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
[TBL] [Abstract][Full Text] [Related]
9. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
[TBL] [Abstract][Full Text] [Related]
10. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
Tallaj JA; Franco V; Rayburn BK; Pinderski L; Benza RL; Pamboukian S; Foley B; Bourge RC
J Heart Lung Transplant; 2005 Dec; 24(12):2196-201. PubMed ID: 16364871
[TBL] [Abstract][Full Text] [Related]
11. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
[TBL] [Abstract][Full Text] [Related]
12. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.
Green P; Anshelevich M; Talreja A; Burcham JL; Ravi SM; Shirani J; Le Jemtel TH
Am J Cardiol; 2005 May; 95(9):1114-6. PubMed ID: 15842987
[TBL] [Abstract][Full Text] [Related]
15. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
16. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
Cinquegrana G; D'Aniello L; Landi M; Spinelli L; Grande G; De Prisco F; Petretta M
J Card Fail; 2005 Apr; 11(3):213-9. PubMed ID: 15812750
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.
Takemoto Y; Hozumi T; Sugioka K; Takagi Y; Matsumura Y; Yoshiyama M; Abraham TP; Yoshikawa J
J Am Coll Cardiol; 2007 Feb; 49(7):778-83. PubMed ID: 17306707
[TBL] [Abstract][Full Text] [Related]
18. Does beta-blocker treatment influence central sleep apnoea?
Köhnlein T; Welte T
Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328
[TBL] [Abstract][Full Text] [Related]
19. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
